Dmitri Pissarnitski

883 total citations
27 papers, 485 citations indexed

About

Dmitri Pissarnitski is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Dmitri Pissarnitski has authored 27 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Dmitri Pissarnitski's work include Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Computational Drug Discovery Methods (8 papers). Dmitri Pissarnitski is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Computational Drug Discovery Methods (8 papers). Dmitri Pissarnitski collaborates with scholars based in United States. Dmitri Pissarnitski's co-authors include Leo A. Paquette, Louis Barriault, Zhiqiang Zhao, John W. Clader, William J. Greenlee, Jeffrey N. Johnston, Lixin Song, Eric M. Parker, Lynn A. Hyde and Theodros Asberom and has published in prestigious journals such as Journal of the American Chemical Society, ACS Catalysis and Journal of Medicinal Chemistry.

In The Last Decade

Dmitri Pissarnitski

27 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitri Pissarnitski United States 15 238 194 102 98 81 27 485
C. DUFRESNE United States 8 109 0.5× 284 1.5× 248 2.4× 66 0.7× 37 0.5× 14 616
Wen‐Lian Wu United States 15 479 2.0× 243 1.3× 47 0.5× 36 0.4× 46 0.6× 38 747
Figueroa‐Valverde Lauro Mexico 13 175 0.7× 185 1.0× 43 0.4× 39 0.4× 51 0.6× 127 632
Brian A. McKittrick United States 16 396 1.7× 306 1.6× 101 1.0× 105 1.1× 54 0.7× 43 714
Theodros Asberom United States 12 267 1.1× 171 0.9× 90 0.9× 70 0.7× 59 0.7× 19 516
Brian P. Slingsby United Kingdom 12 291 1.2× 371 1.9× 191 1.9× 81 0.8× 46 0.6× 16 718
Susan Petusky United States 9 126 0.5× 225 1.2× 59 0.6× 101 1.0× 30 0.4× 10 567
Nuria Fraiz Spain 11 397 1.7× 174 0.9× 124 1.2× 30 0.3× 48 0.6× 17 674
Bernard Hulin United States 15 339 1.4× 307 1.6× 101 1.0× 21 0.2× 48 0.6× 23 645
Katerina Otrubova United States 12 172 0.7× 299 1.5× 250 2.5× 23 0.2× 20 0.2× 15 563

Countries citing papers authored by Dmitri Pissarnitski

Since Specialization
Citations

This map shows the geographic impact of Dmitri Pissarnitski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitri Pissarnitski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitri Pissarnitski more than expected).

Fields of papers citing papers by Dmitri Pissarnitski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitri Pissarnitski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitri Pissarnitski. The network helps show where Dmitri Pissarnitski may publish in the future.

Co-authorship network of co-authors of Dmitri Pissarnitski

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitri Pissarnitski. A scholar is included among the top collaborators of Dmitri Pissarnitski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitri Pissarnitski. Dmitri Pissarnitski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shasha, Dmitri Pissarnitski, Timothy Nowak, Michael Wleklinski, & Shane W. Krska. (2022). Merging Late-Stage Diversification with Solid-Phase Peptide Synthesis Enabled by High-Throughput On-Resin Reaction Screening. ACS Catalysis. 12(5). 3201–3210. 8 indexed citations
2.
Zhao, Zhiqiang, Dmitri Pissarnitski, Xianhai Huang, et al.. (2017). Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators. ACS Medicinal Chemistry Letters. 8(10). 1002–1006. 10 indexed citations
3.
Pissarnitski, Dmitri, Zhiqiang Zhao, David Cole, et al.. (2016). Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5534–5545. 13 indexed citations
4.
Zhao, Zhiqiang, Dmitri Pissarnitski, Hubert Josien, et al.. (2016). Substituted 4-morpholine N -arylsulfonamides as γ-secretase inhibitors. European Journal of Medicinal Chemistry. 124. 36–48. 12 indexed citations
5.
Wu, Wen‐Lian, Jinsong Hao, Martin S. Domalski, et al.. (2016). Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4 Inhibitors for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 7(5). 498–501. 38 indexed citations
6.
Zhao, Zhiqiang, Dmitri Pissarnitski, Hubert Josien, et al.. (2015). Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors. Journal of Medicinal Chemistry. 58(22). 8806–8817. 19 indexed citations
7.
Huang, Xianhai, Dmitri Pissarnitski, Hongmei Li, et al.. (2012). Efficient synthesis and reaction pathway studies of novel fused morpholine oxadiazolines for use as gamma secretase modulators. Tetrahedron Letters. 53(47). 6451–6455. 8 indexed citations
8.
Qin, Jun, Xianhai Huang, Mihirbaran Mandal, et al.. (2010). Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 21(2). 664–669. 19 indexed citations
9.
Josien, Hubert, Thomas Bara, Theodros Asberom, et al.. (2007). Small conformationally restricted piperidine N-arylsulfonamides as orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(19). 5330–5335. 15 indexed citations
10.
McBriar, Mark D., John W. Clader, Inhou Chu, et al.. (2007). Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 215–219. 37 indexed citations
11.
Li, Hongmei, Theodros Asberom, Thomas Bara, et al.. (2007). Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(22). 6290–6294. 16 indexed citations
12.
Vaccaro, Henry A., Zhiqiang Zhao, John W. Clader, et al.. (2007). Solution-Phase Parallel Synthesis of Carbamates as γ-Secretase Inhibitors. Journal of Combinatorial Chemistry. 10(1). 56–62. 6 indexed citations
13.
Asberom, Theodros, Thomas Bara, John W. Clader, et al.. (2006). Tetrahydroquinoline sulfonamides as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(1). 205–207. 27 indexed citations
14.
Asberom, Theodros, Zhiqiang Zhao, Thomas Bara, et al.. (2006). Discovery of γ-secretase inhibitors efficacious in a transgenic animal model of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 17(2). 511–516. 21 indexed citations
15.
16.
Pissarnitski, Dmitri. (2005). Phosphodiesterase 5 (PDE 5) inhibitors for the treatment of male erectile disorder: Attaining selectivity versus PDE6. Medicinal Research Reviews. 26(3). 369–395. 38 indexed citations
17.
Pissarnitski, Dmitri, Theodros Asberom, Samuel Chackalamannil, et al.. (2004). SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction. Bioorganic & Medicinal Chemistry Letters. 14(5). 1291–1294. 16 indexed citations
18.
Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2002). Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(21). 3149–3152. 29 indexed citations
19.
Paquette, Leo A., Louis Barriault, Dmitri Pissarnitski, & Jeffrey N. Johnston. (2000). ChemInform Abstract: Stereocontrolled Elaboration of Natural (‐)‐Polycavernoside A, a Powerfully Toxic Metabolite of the Red Alga Polycavernosa tsudai.. ChemInform. 31(19). 2 indexed citations
20.
Paquette, Leo A., Louis Barriault, Dmitri Pissarnitski, & Jeffrey N. Johnston. (1999). Stereocontrolled Elaboration of Natural (−)-Polycavernoside A, a Powerfully Toxic Metabolite of the Red Alga Polycavernosa tsudai. Journal of the American Chemical Society. 122(4). 619–631. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. DUFRESNE Breakdown of academic impact, for papers by Wen‐Lian Wu Breakdown of academic impact, for papers by Figueroa‐Valverde Lauro Breakdown of academic impact, for papers by Brian A. McKittrick Breakdown of academic impact, for papers by Theodros Asberom Breakdown of academic impact, for papers by Brian P. Slingsby Breakdown of academic impact, for papers by Susan Petusky Breakdown of academic impact, for papers by Nuria Fraiz Breakdown of academic impact, for papers by Bernard Hulin Breakdown of academic impact, for papers by Katerina Otrubova
Rankless by CCL
2026